HOXB13

homeobox B13, the group of HOXL subclass homeoboxes

Basic information

Region (hg38): 17:48724763-48728750

Links

ENSG00000159184NCBI:10481OMIM:604607HGNC:5112Uniprot:Q92826AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • prostate cancer, hereditary, 9 (Strong), mode of inheritance: AD
  • prostate cancer (Definitive), mode of inheritance: AD

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the HOXB13 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the HOXB13 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
254
clinvar
2
clinvar
258
missense
613
clinvar
1
clinvar
614
nonsense
30
clinvar
30
start loss
4
clinvar
4
frameshift
51
clinvar
51
inframe indel
9
clinvar
9
splice donor/acceptor (+/-2bp)
3
clinvar
3
splice region
7
4
11
non coding
3
clinvar
19
clinvar
5
clinvar
27
Total 0 0 715 274 7

Variants in HOXB13

This is a list of pathogenic ClinVar variants found in the HOXB13 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
17-48726629-A-AG Prostate cancer, hereditary, 1 Uncertain significance (-)691033
17-48726634-G-GC Prostate cancer, hereditary, 1 Uncertain significance (-)691031
17-48726636-TC-T Prostate cancer, hereditary, 1 Uncertain significance (-)691029
17-48726637-C-T Prostate cancer, hereditary, 1 Uncertain significance (-)691030
17-48726638-C-G Prostate cancer, hereditary, 1 Uncertain significance (-)691028
17-48726638-C-CG Prostate cancer, hereditary, 1 Uncertain significance (-)691027
17-48726640-GA-G Prostate cancer, hereditary, 1 Uncertain significance (-)691026
17-48726640-G-GC Prostate cancer, hereditary, 1 Uncertain significance (-)691025
17-48726642-G-T Prostate cancer, hereditary, 1 Uncertain significance (-)691024
17-48726643-GA-G Prostate cancer, hereditary, 1 Uncertain significance (-)691021
17-48726644-A-C Prostate cancer, hereditary, 1 Uncertain significance (-)691023
17-48726644-A-G Prostate cancer, hereditary, 1 Uncertain significance (-)691022
17-48726646-CA-C Prostate cancer, hereditary, 1 Uncertain significance (-)691230
17-48726648-G-T Prostate cancer, hereditary, 1 Uncertain significance (-)691020
17-48726650-C-A Prostate cancer, hereditary, 1 Uncertain significance (-)691019
17-48726650-C-G Prostate cancer, hereditary, 1 Uncertain significance (-)691018
17-48726651-CA-C Prostate cancer, hereditary, 1 Uncertain significance (-)691016
17-48726652-A-C Prostate cancer, hereditary, 1 Uncertain significance (-)691017
17-48726653-G-A Prostate cancer, hereditary, 1 Uncertain significance (-)691015
17-48726653-G-T Prostate cancer, hereditary, 1 Uncertain significance (-)691014
17-48726654-C-G Prostate cancer, hereditary, 1 Uncertain significance (-)691229
17-48726655-A-C Prostate cancer, hereditary, 1 Uncertain significance (-)691013
17-48726658-C-G Prostate cancer, hereditary, 1 Uncertain significance (-)691012
17-48726658-C-T Prostate cancer, hereditary, 1 Uncertain significance (-)691011
17-48726658-CA-C Prostate cancer, hereditary, 1 Uncertain significance (-)691008

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
HOXB13protein_codingprotein_codingENST00000290295 24416
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
3.69e-80.1061257190291257480.000115
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.004151661661.000.000008401803
Missense in Polyphen5558.3710.94224699
Synonymous-0.5887972.61.090.00000391614
Loss of Function-0.2081110.31.074.95e-7113

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002390.000239
Ashkenazi Jewish0.00009930.0000992
East Asian0.00005440.0000544
Finnish0.000.00
European (Non-Finnish)0.0001500.000149
Middle Eastern0.00005440.0000544
South Asian0.0001310.000131
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis. Binds preferentially to methylated DNA (PubMed:28473536). {ECO:0000269|PubMed:28473536}.;
Disease
DISEASE: Prostate cancer (PC) [MIM:176807]: A malignancy originating in tissues of the prostate. Most prostate cancers are adenocarcinomas that develop in the acini of the prostatic ducts. Other rare histopathologic types of prostate cancer that occur in approximately 5% of patients include small cell carcinoma, mucinous carcinoma, prostatic ductal carcinoma, transitional cell carcinoma, squamous cell carcinoma, basal cell carcinoma, adenoid cystic carcinoma (basaloid), signet-ring cell carcinoma and neuroendocrine carcinoma. {ECO:0000269|PubMed:22236224, ECO:0000269|PubMed:22714738, ECO:0000269|PubMed:23064873, ECO:0000269|PubMed:23292082, ECO:0000269|PubMed:25629170, ECO:0000269|PubMed:27424772}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
Pathway
Regulation of Androgen receptor activity (Consensus)

Recessive Scores

pRec
0.147

Intolerance Scores

loftool
0.364
rvis_EVS
-0.07
rvis_percentile_EVS
48.12

Haploinsufficiency Scores

pHI
0.238
hipred
N
hipred_score
0.490
ghis
0.408

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.990

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Hoxb13
Phenotype
behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; reproductive system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; cellular phenotype; endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;angiogenesis;epidermis development;response to wounding;response to testosterone;regulation of growth;prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis;epithelial cell maturation involved in prostate gland development
Cellular component
nucleoplasm;transcription factor complex
Molecular function
DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;methyl-CpG binding;sequence-specific DNA binding